| Code | 4695D | ||||||||||
| MA number | 16/0131/20-S | ||||||||||
| Product Form: | tbl flm 14x20 mg (blis.PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Zentiva k.s., Czechia | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 04.06.2020 |
| SPC: |
SPC_Xanirva 20 mg_ tbl flm_03_2024.pdf
|
| PIL: |
PIL_Xanirva 15 mg_ 20 mg_tbl flm_03_2024.pdf
|
| Dokument: |
Príručka pre lekára_rivaroxabán_V3.pdf
|
| Safety feature | Yes |
| Data update: | 26.08.2024 |
